[1]
Neuman, M.G. et al. 2020. Gamma glutamyl transferase – an underestimated marker for cardiovascular disease and the metabolic syndrome. Journal of Pharmacy & Pharmaceutical Sciences. 23, 1 (Apr. 2020), 65–74. DOI:https://doi.org/10.18433/jpps30923.